Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)- induced DNA synthesis and collagen gel contraction

Journal of Clinical Investigation

Volumn 98, Issue 10, 1996, Pages 2218-2227

  Ashizawa, Naoto ^a   Graf, Kristof ^c   Do, Yung S ^a   Nunohiro, Tatsuya ^a   Giachelli, Cecilia M ^d   Meehan, Woerner P ^a   Tuan, Tai Lan ^b   Hsueh, Willa A ^a,e  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e LAC USC MEDICAL CENTER   (United States)

Author keywords

angiotensin II; cardiac fibroblasts; cardiac hypertrophy; collagen gel contraction; osteopontin

Indexed keywords

ANGIOTENSIN; COLLAGEN GEL; INTEGRIN; LOSARTAN; MESSENGER RNA; OSTEOPONTIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; EXTRACELLULAR MATRIX; FIBROBLAST; HEART HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION;

EID: 0029844965     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119031     Document Type: Article

References (44)

1. Denhardt, D., and X. Guo. 1993. Osteopontin: a protein with diverse functions. FASEB (Fed. Am. Soc. Exp. Biol.) J. 7:1475-1482.
2. Giachelli, C., N. Bae, M. Almeida, D. Denhardt, C.E. Alpers, and S.M. Schwartz. 1993. Osteopontin expression is elevated during neointima formation in rat arteries and in human atherosclerotic plaques. J. Clin. Invest. 92:1686-1696.
3. Liaw, L., M. Almeida, W. Downey, C.E. Hart, S.M. Schwartz, and C.M. Giachelli. 1994. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle in vitro. Circ. Res. 74:214-224.
4. Chen, Y., B.S. Balt, and J.P. Gorski. 1992. Calcium and collagen binding properties of osteopontin, bone sialoprotein, and bone acidic glycoprotein-75 from bone. J. Biol. Chem. 287:24871-24878.
5. Butler, W.T. 1989. The nature and significance of osteopontin. Connect. Tissue Res. 23:123-136.
6. 3 in smooth muscle migration to osteopontin in vitro. J. Clin. Invest. 95:713-724.
7. 3 integrin with a small peptide antagonist GpenGRGDSPCA. J. Vasc. Surg. 19:124-134.
8. EPIC Investigators. 1994. Use of a monoclonal antibody directed against platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N. Engl. J. Med. 330:956-961.
9. Murry, C.E., C.M. Giachelli, S.M. Schwartz, and R. Vracko. 1994. Macrophages express osteopontin during repair of myocardial necrosis. Am. J. Pathol. 145:1450-1462.
10. Williams, E.B., L. Halpert, S. Wickline, G. Davison, W.C. Parks, and J.N. Rottman. 1995. Osteopontin expression is increased in the heritable cardiomyopathy of Syrian hamsters. Circulation. 92:705-709.
11. Singh, K., J.-L. Balligandt, T.A. Fischer, T.W. Smith, and R.A. Kelly. 1995. Glucocorticoids increase osteopontin expression in cardiac myocytes and microvascular endothelial cells. J. Biol. Chem. 270:28471-28474.
12. Linz, W., B.A. Schoelkens, and D. Ganten. 1989. Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin. Exp. Hypertens. 11:1325-1350.
13. Dahloef, B., K. Pennert, and L. Hansson. 1992. Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am. J. Hypertens. 5:95-110.
14. SAVE Investigators. 1992. Effect of captopril on morbidity and mortality in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N. Engl. J. Med. 327:669-677.
15. GISSI-3 Coordinating Centre. 1994. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet. 343:1115-1122,
16. Sadoshima, J., X. Yuhui, H.S. Slater, and S. Izumo. 1993. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 75:977-984.
17. Baker, K.M., G.W. Booz, and D.E. Dostal. 1992. Cardiac actions of angiotensin II: role of an intracardiac renin-angiotensin system. Annu. Rev. Physiol. 54:227-241.
18. Morkin, E., and T.P. Ashford. 1968. Myocardial DNA synthesis in experimental cardiac hypertrophy. Am. J. Physiol. 215:1409-1413.
19. Weber, K.T., J.S. Janicki, S.G. Shroff, R. Pick, R.M. Chen, and R.I. Bashey. 1988. Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium. Circ. Res. 62:757-765.
20. Villarreal, F.J., N.N. Kim, G.D. Ungab, M.P. Printz, and W.H. Dillmann. 1993. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation. 88:2849-2861.
21. Matsubara, H., M. Kanasaki, S. Murasawa, Y. Tsukaguchi, Y. Nio, and M. Inada. 1994. Differential gene expression and regulation of angiotensin II receptor subtypes in rat cardiac fibroblasts and cardiomyocytes in culture. J. Clin. Invest. 93:1592-1601.
22. Iwami, K., N. Ashizawa, Y.S. Do, K. Graf, and W.A. Hsueh. 1996. Comparison of angiotensin II with other growth factors on EGR-1 and matrix gene expression in cardiac fibroblasts. Am. J. Physiol. 270:H2100-H2107.
23. Schieffer, B.A., A. Wirger, M. Meybrunn, S. Seitz, J. Holtz, U.N. Riede, and H. Drexler. 1994. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation. 89:2273-2282.
24. Buchanan, T.A., G.F. Sipos, S. Gadallah, K.P. Yip, D.J. Marsh, W.A. Hsueh, and R. Bergman. 1991. Glucose tolerance and insulin action in rats with renovascular hypertension. Hypertension (Dallas). 18:341-347.
25. Chomczynski, P.S., and N. Sacchi. 1989. Single step method of RNA isolation by acid guanidinium hemocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
26. Harpold, M.M., R.M. Evans, M. Saidtt-Georgieff, and J.E. Darnell. 1979. Production of mRNA in Chinese hamster cells; relationship of the rate of synthesis to the cytoplasmic concentration of nine specific mRNA sequences. Cell. 17:1025-1035.
27. Helfrich, M.H., S.A. Nesbitt, and M.A. Horton. 1992. Integrins on rat osteoclasts: characterization of two monoclonal antibodies (F4 and F-11) to rat β3. J. Bone Miner. Res. 7:345-351.
28. Sollot, S.J., L. Cheng, R.R. Pauly, G.M. Jenkins, R.E. Monticone, M. Kuzuya, J.P. Froelich, M.T. Crow, E.G. Lakatta, E.K. Rowinsky, and J.L. Kinsella. 1995. Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat. J. Clin. Invest. 95:1869-1876.
29. Guidry, C., and F. Grinnell. 1986. Contraction of hydrated collagen gels by fibroblasts: evidence for two mechanisms by which collagen fibrils are stabilized. Collagen Relat. Res. 6:515-529.
30. Giachelli, C.M., S.M. Schwartz, and L. Liaw. 1995. Molecular and cellular biology of osteopontin. Trends Cardiovasc. Med. 5:88-95.
31. Rodan, G.A. 1995. Osteopontin overview. NY Acad. Sci. 1 pp.
32. Gardner, H.A., B. Berse, and D.R. Senger. 1994. Specific reduction in osteopontin synthesis by antisense RNA inhibits the tumorigenicity of transformed Rat1 fibroblasts. Oncogene. 9:2321-2326.
33. Brown, L.F., B. Berse, L. Van De Water, A.P. Sergio, C.A. Perruzzt, E.J. Manseau, H.F. Dvorak, and D.R. Singer. 1992. Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. Mol. Biol. Cell. 3:1169-1180.
34. Harter, L.V., K.A. Hruska, and R.L. Duncan. 1995. Human osteoblast-like cells respond to mechanical strain with increased bone matrix protein production independent of hormonal regulation. Endocrinology. 136:528-535.
35. Everette, A.D., A. Tufro-McReddie, A. Fisher, and R.A. Gomez. 1994. Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-beta 1 expression. Hypertension (Dallas). 23:587-592.
36. Mamuya, W.S., and P. Brecher. 1992. Fibronectin expression in the normal and hypertrophie rat. J. Clin. Invest. 89:392-401.
37. Boluyt, M.O., L. O'Neill, A.L. Meredith, O.H.L. Bing, W.W. Brooks, C.H. Conrad, M.T. Crow, and E.G. Lakatta. 1994. Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure. Circ. Res. 75:23-32.
38. Gillery, P., F.X. Marquat, and J.P. Borel. 1986. Fibronectin dependence of the contraction of collagen by human skin fibroblasts. Exp. Cell Res. 167:29-37.
39. Mukherjee, B.B., M. Nemir, S. Beninati, E. Cordella-Miele, K. Singh, I. Chackalaparampil, V. Shanmugam, M.W. DeVouge, and A.B. Mukherjee. 1995. Interaction of osteopontin with fibronectin and other extracellular matrix molecules. Ann. NY Acad. Sci. 760:201-212.
40. 5) is responsible for distinct adhesive properties of carcinoma cells. Cell. 57:59-69.
41. Juliano, R.L., and S. Haskill. 1993. Signal transduction from the extracellular matrix. J. Cell Biol. 120:577-585.
42. Hynes, R.O. 1992. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 69:11-25.
43. Burgess, M.L., W.E. Carver, L. Terracio, S.P. Wilson, W.A. Wilson, and T.K. Borg. 1994. Integrin-mediated collagen gel contraction by cardiac fibroblasts; effects of angiotensin II. Circ. Res. 74:291-298.
44. Knowlton, K.U., M.C. Michel, M. Itani, H.E. Shubeita, K. Ishihara, J.H. Brown, and K.R. Chien. 1993. The alpha 1 A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy. J. Biol. Chem. 268:15374-15380.